Research

Students from laboratories affiliated with the Department of Biochemistry shared their findings during the department's annual Research Day.

Jessy J. Alexander, PhD, research professor of medicine in the Division of Nephrology, has received funding to study complement activation and its role in kidney disease.

The Hunter James Kelly Research Institute (HJKRI) has received more than $2 million in National Institutes of Health (NIH) funding, enabling researchers to pursue a new approach to Krabbe disease.

The Jacobs School of Medicine and Biomedical Sciences is among 72 sites nationwide that are recruiting patients for a 12-week, randomized, placebo-controlled drug trial for the first treatment designed to benefit patients with mild-to-moderate Lewy body dementia (LBD).

Thirty-four original research projects from aspiring physician-scientists were on display at the 2019 Medical Student Research Forum.

Students from laboratories affiliated with the Genetics, Genomics and Bioinformatics graduate program (GGB) shared their findings during the fifth annual GGB Research Day.

Research by Gil I. Wolfe, MD, UB Distinguished Professor and Irvin and Rosemary Smith Chair of the Department of Neurology, shows that surgery to remove the thymus gland in patients with myasthenia gravis (MG) provides significant clinical benefits for as long as five years after the procedure.

New stem cell research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified novel therapeutic targets for the treatment of multiple sclerosis (MS) and other inflammatory diseases.

Research by John J. Leddy, MD, clinical assistant professor of orthopaedics, and Barry S. Willer, PhD, professor of psychiatry, did not find evidence of early-onset dementia (EOD) in a study of retired National Football League and National Hockey League players.